Next |
home / stock / sabs / sabs message board
Subject | By | Source | When |
---|---|---|---|
$SABS bears are running | XenaLives | investorshub | 05/14/2023 11:30:21 PM |
$SABS should we be shorting? | crudeoil24 | investorshub | 05/13/2023 2:03:54 AM |
Price gaining | XenaLives | investorshub | 05/11/2023 12:26:26 AM |
The gaining | XenaLives | investorshub | 05/09/2023 12:34:18 PM |
$SABS The now | XenaLives | investorshub | 05/06/2023 2:17:08 PM |
$SABS bulls and bears | XenaLives | investorshub | 04/26/2023 10:46:45 PM |
$SABS Have a look at this | Awl416 | investorshub | 04/26/2023 7:06:11 AM |
Looks pretty positive | XenaLives | investorshub | 04/20/2023 5:13:56 PM |
Have a look at this | Jess070283 | investorshub | 04/19/2023 10:59:58 PM |
My swinger is aliveeee | Jess070283 | investorshub | 04/18/2023 2:11:23 PM |
1.11 High PM | Golden Cross | investorshub | 04/13/2023 12:13:34 PM |
Moving PM | Awl416 | investorshub | 04/13/2023 12:01:48 PM |
Historic short interest: | XenaLives | investorshub | 05/21/2022 1:32:00 AM |
Another great trade.$$$ Up up we go! | Jess070283 | investorshub | 03/31/2022 6:43:03 PM |
SABs government contract work is expected to provide | crudeoil24 | investorshub | 03/31/2022 6:24:02 PM |
Historic short interest: | XenaLives | investorshub | 03/17/2022 11:19:10 PM |
Historic short interest: | XenaLives | investorshub | 01/27/2022 1:54:22 PM |
Historic short interest: | XenaLives | investorshub | 12/30/2021 1:35:57 PM |
Chasing Stars: SABS Stock Chart Video Analysis 11-27-2021 SAB Biotherapeutics Inc. $SABS Today we ta | Chasing Stars | investorshangout | 11/27/2021 8:56:43 PM |
Historic short interest: | XenaLives | investorshub | 11/24/2021 10:02:36 PM |
News, Short Squeeze, Breakout and More Instantly...
SAB Biotherapeutics Inc. Company Name:
SABS Stock Symbol:
NASDAQ Market:
SAB Biotherapeutics Inc. Website:
SAB Biotherapeutics, Inc. (NASDAQ: SABS) is one of today's top gainers. The company's shares have moved 0% on the day to $2.77. SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advance...
New name, logo and website updates, stock symbol will remain SABS With new brand identity, SAB BIO continues drive towards serious unmet needs in type 1 diabetes MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB...
MIAMI, June 18, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progre...